Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-07-22Clinical Trial Update: Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT) [Phase 4]
Phase 4 trial update comparing Macular Epiretinal Brachytherapy to Lucentis-only treatment for macular degeneration; results have been poste…
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device [NA]
Clinical trial update on home vision monitoring (ForeseeHome) for progression to neovascular age-related macular degeneration in AREDS2 part…
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD [Phase 2]
Phase 2A open-label safety study of Fovista in combination with anti-VEGF therapy for sub-retinal fibrosis in neovascular age-related macula…
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections [NA]
A completed clinical trial evaluating topical proparacaine eye drops to improve patient experience during intravitreal injections for age-re…
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT) [Phase 4]
Phase 4 trial comparing ranibizumab monotherapy versus ranibizumab combined with verteporfin photodynamic therapy for symptomatic macular po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients [Phase 4]
Phase 4 clinical trial comparing ranibizumab and aflibercept for development of geographic atrophy in wet age-related macular degeneration; …
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: French Evaluation Group Avastin Versus Lucentis [Phase 3]
Phase 3 trial comparing Avastin to Lucentis for age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration [Phase 3]
Phase 3 trial of lampalizumab for geographic atrophy due to age-related macular degeneration was terminated with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration [Phase 2]
Phase 2 safety and efficacy trial of brimonidine intravitreal implant for geographic atrophy due to age-related macular degeneration was ter…
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection [NA]
A completed pilot randomized trial evaluating anesthetic agents for intravitreal injections in macular degeneration; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration [Phase 3]
Phase 3 trial investigating lampalizumab for geographic atrophy due to age-related macular degeneration was terminated; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer) [Phase 2]
A 24-month Phase 2a open-label randomized study evaluated Avastin, Lucentis, or Eylea in combination with Fovista for age-related macular de…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Intravitreal Aflibercept for Submacular Hemorrhage [Phase 4]
The document reports the completion of a Phase 4 clinical trial evaluating intravitreal aflibercept for submacular hemorrhage in exudative a…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of Lucentis (ranibizumab) in Chilean patients with diabetic macular edema has comp…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) [Phase 3]
Phase 3 trial update on long-term safety of lampalizumab intravitreal injections in geographic atrophy due to age-related macular degenerati…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device
A completed clinical trial evaluating geographic atrophy measurements in age-related macular degeneration using the Nidek MP-3 microperimetr…
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: Brain Connectivity in Age-Related Macular Degeneration
A Duke University–sponsored clinical trial investigating brain connectivity in age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging
A clinical trial evaluating hyperspectral imaging to enhance management of choroidal neovascular membranes in age-related macular degenerati…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Prevalence of Age Related Macular Degeneration (ARMD) in Parkinson's Patients and Assesment of the Role of L-DOPA
This clinical trial update summarizes a completed study evaluating the prevalence of age-related macular degeneration in Parkinson disease p…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: OCT and Microperimetry in Patients With Active Neovascular ARMD (CORFI)
This clinical trial update describes a study evaluating OCT and microperimetry in patients with active neovascular age-related macular degen…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Effect Aflibercept on Ocular Perfusion [Phase 4]
Phase 4 trial update investigating the effect of aflibercept on ocular perfusion in macular degeneration.
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: Intense Treatment Regimen With Intravitreal Aflibercept Injection [Phase 1, Phase 2]
Phase 1/2 trial evaluating an intense intravitreal aflibercept treatment regimen for neovascular age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD [Phase 2]
Phase 2 safety and preliminary efficacy study of WST11-mediated VTP therapy in CNV associated with AMD was terminated; results posted in 201…
-
CLINICAL_TRIALS trial_result · 2018-09-07Clinical Trial Update: To Evaluate The Role of Intravitreal Aflibercept Injection (2.0 mg) in the Management of Previously Treated Patients With Exudative AMD [Phase 4]
Phase 4 trial evaluating intravitreal aflibercept (2.0 mg) for previously treated exudative AMD with persistent or recurrent fluid.
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection [Phase 2]
Phase 2 trial update for Ziv-aflibercept in ocular diseases requiring anti-VEGF injections.